BioNTech, Duality Biologics sign $1.5 billion pact for cancer drugs
HQ Team April 3, 2023: BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer.
Drugs
Medical
Pharma
Drugs
Health
Pharma
FDA to permit salt substitutes to fight heart disease in US
The US FDA plans to permit the use of salt substitutes in daily food, such as bread, cheeses and ketchup, to reduce the.
Drugs
Medical
Pharma
FDA nod for Pfizer-Biotech vaccine booster for children
The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four.
Drugs
Medical
Alembic Pharma gets USFDA approval for cancer treatment drug
Alembic Pharmaceuticals got the USFDA note for a generic cancer treatment drug
Drugs
Pharma
Moderna-Merck’s cancer vaccine gets FDA breakthrough therapy designation
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received.
Drugs
Medical
Pharma
Merck’s pill fails to prevent COVID-19 infection among households
Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.
Drugs
Medical
Pharma
GE Healthcare recalls 688 medical systems, FDA says ‘most serious’
GE Healthcare has pulled out 688 medical systems that evaluate diseases, trauma, abnormalities and disorders, a move which USFDA termed a most severe.
Drugs
Pharma
FDA puts on hold Blueprint Medicines’ clinical trial for solid cancers
The USFDA has put on hold Blueprint Medicines Corporation's clinical trial of BLU-222 due to visual adverse events seen in some patients, according.
Drugs
Health
Pharma
FDA recommends new rules for cannabidiol products
The FDA has suggested new regulations for the use of cannabidiol products, as the existing rules on food and supplements were insufficient for.
Drugs
Pharma
US regulatory nod for Lupin’s HIV drug in the works
Pharma major Lupin has received a ‘tentative approval’, from the United States Food and Drug Administration (FDA), to market medicines used to treat.